CDC Website CDC Website

To Join the NPIN community or

Home » High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Funding Organization
National Institutes of Health
Funding Category
HIV/AIDS
Support Types
Officers and Trustees Discretionary Grants
Locations
National
Eligible Organizations
City Agencies
Colleges/Universities
Commercial Organizations
Community Based Organizations
County Agencies
Federal Government Agencies
IRS 501 (c)(3) Organizations
Nonprofit Organizations
Religious Organizations
State Agencies
Tribal Organizations
Number of Awards Given
Three to five awards.

Maximum Amount: 

3500000.00
Letter of Intent Date
1/15/22
Application Due Date
2/15/22
Project Start Date
12/1/22
Application Contact
Pamela
Fleming
Chief Grants Management Officer
301-480-1159
pfleming@nida.nih.gov
Technical Contact
Vasundhara
Varthakavi, DVM, PhD
Associate Director
vasundhara.varthakavi@nih.gov
301-443-2146
Fund Duration
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Subjects
Drug Abuse
HIV
Research
Audiences
Researchers

Fund Number: 

360924

Fund ID: 

RFA-DA-22-040

Last modified: 

9/8/21